Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Recurrence, Local × Lomustine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 12 Glioma 4 Brain Neoplasms 4 Medulloblastoma 3 Recurrence 2 Oligodendroglioma 2 Central Nervous System Neoplasms 2 Neoplasms 1 Neoplasm Recurrence, Local 1 Gliosarcoma 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Astrocytoma 1

Interventions

pembrolizumab 1 Spinal Puncture 1 Radiotherapy 1 Paclitaxel 1 Lomustine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07100730 2026-03-12

IPAX BrIGHT

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 3 Recruiting

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡